MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,773.95
+0.66%
NASDAQ 100
$31,076.44
+0.87%
DOW JONES
$51,268.00
+0.18%
NASDAQ Composite
$27,477.31
+1.05%
RUSSELL 2000
$2,833.80
+0.66%
CBOE VIX
$15.52
+1.37%
Sector Heatmap
Technology+0.56%
Financials+0.73%
Healthcare+0.72%
Consumer Cycl+0.35%
Consumer Staples+0.63%
Energy+0.99%
Industrials+0.09%
Materials+1.31%
Real Estate-0.34%
Utilities+0.35%
Comm Services+1.17%
HURA — TuHURA Biosciences, Inc. Common Stock
NasdaqTuHURA Biosciences, Inc. Common Stock
$1.87
-0.04(-2.09%)
- O
- 1.94
- H
- 1.94
- L
- 1.85
- V
- 333.98K
⏱️ End-of-day dataAs of Oct 5, 2026
Chart
About HURA
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateOct 18, 2024
Employees22
Stock ExchangeNasdaq
Ticker SymbolHURA
Websitehttps://www.tuhurabio.com
Key Financial Statistics
| Market Cap | $121.72M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $0.41 - $3.43 |
| 52-Week Avg Volume | 780.6K |
| VWAP | $1.88 |
| Transactions | 2,191 |
| Total Recorded Bars | 3,425 days |